Literature DB >> 25996669

Elemental bioimaging of Cisplatin in Caenorhabditis elegans by LA-ICP-MS.

Barbara Crone1, Michael Aschner, Tanja Schwerdtle, Uwe Karst, Julia Bornhorst.   

Abstract

cis-Diamminedichloroplatinum(II) (Cisplatin) is one of the most important and frequently used cytostatic drugs for the treatment of various solid tumors. Herein, a laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) method incorporating a fast and simple sample preparation protocol was developed for the elemental mapping of Cisplatin in the model organism Caenorhabditis elegans (C. elegans). The method allows imaging of the spatially-resolved elemental distribution of platinum in the whole organism with respect to the anatomic structure in L4 stage worms at a lateral resolution of 5 μm. In addition, a dose- and time-dependent Cisplatin uptake was corroborated quantitatively by a total reflection X-ray fluorescence spectroscopy (TXRF) method, and the elemental mapping indicated that Cisplatin is located in the intestine and in the head of the worms. Better understanding of the distribution of Cisplatin in this well-established model organism will be instrumental in deciphering Cisplatin toxicity and pharmacokinetics. Since the cytostatic effect of Cisplatin is based on binding the DNA by forming intra- and interstrand crosslinks, the response of poly(ADP-ribose)metabolism enzyme 1 (pme-1) deletion mutants to Cisplatin was also examined. Loss of pme-1, which is the C. elegans ortholog of human poly(ADP-ribose) polymerase 1 (PARP-1) led to disturbed DNA damage response. With respect to survival and brood size, pme-1 deletion mutants were more sensitive to Cisplatin as compared to wildtype worms, while Cisplatin uptake was indistinguishable.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25996669      PMCID: PMC4497950          DOI: 10.1039/c5mt00096c

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  45 in total

1.  The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy.

Authors:  M Javle; N J Curtin
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

Review 2.  Laser ablation ICP-MS for quantitative biomedical applications.

Authors:  Ioana Konz; Beatriz Fernández; M Luisa Fernández; Rosario Pereiro; Alfredo Sanz-Medel
Journal:  Anal Bioanal Chem       Date:  2012-04-29       Impact factor: 4.142

Review 3.  Hyphenated techniques as tools for speciation analysis of metal-based pharmaceuticals: developments and applications.

Authors:  Björn Meermann; Michael Sperling
Journal:  Anal Bioanal Chem       Date:  2012-04-06       Impact factor: 4.142

Review 4.  Multiple roles for poly(ADP-ribose)polymerase-1 in neurological disease.

Authors:  Tiina M Kauppinen
Journal:  Neurochem Int       Date:  2007-01-12       Impact factor: 3.921

5.  Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells.

Authors:  R H Lee; J M Song; M Y Park; S K Kang; Y K Kim; J S Jung
Journal:  Biochem Pharmacol       Date:  2001-10-15       Impact factor: 5.858

6.  ASNA-1 activity modulates sensitivity to cisplatin.

Authors:  Oskar Hemmingsson; Gautam Kao; Maria Still; Peter Naredi
Journal:  Cancer Res       Date:  2010-10-21       Impact factor: 12.701

Review 7.  Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity.

Authors:  Seong-Woon Yu; Hongmin Wang; Ted M Dawson; Valina L Dawson
Journal:  Neurobiol Dis       Date:  2003-12       Impact factor: 5.996

8.  Cerebral bioimaging of Cu, Fe, Zn, and Mn in the MPTP mouse model of Parkinson's disease using laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS).

Authors:  Andreas Matusch; Candan Depboylu; Christoph Palm; Bei Wu; Günter U Höglinger; Martin K-H Schäfer; J Sabine Becker
Journal:  J Am Soc Mass Spectrom       Date:  2009-10-06       Impact factor: 3.109

Review 9.  Bioimaging of metals by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS).

Authors:  J Sabine Becker; Miroslav Zoriy; Andreas Matusch; Bei Wu; Dagmar Salber; Christoph Palm; J Susanne Becker
Journal:  Mass Spectrom Rev       Date:  2010 Jan-Feb       Impact factor: 10.946

10.  Regulation of chromatin structure by poly(ADP-ribosyl)ation.

Authors:  Sascha Beneke
Journal:  Front Genet       Date:  2012-09-03       Impact factor: 4.599

View more
  6 in total

Review 1.  Caenorhabditis elegans as an emerging model system in environmental epigenetics.

Authors:  Caren Weinhouse; Lisa Truong; Joel N Meyer; Patrick Allard
Journal:  Environ Mol Mutagen       Date:  2018-08-09       Impact factor: 3.216

Review 2.  The base excision repair process: comparison between higher and lower eukaryotes.

Authors:  Nagham Nafiz Hindi; Noha Elsakrmy; Dindial Ramotar
Journal:  Cell Mol Life Sci       Date:  2021-11-03       Impact factor: 9.261

3.  Multiple metabolic changes mediate the response of Caenorhabditis elegans to the complex I inhibitor rotenone.

Authors:  Claudia P Gonzalez-Hunt; Anthony L Luz; Ian T Ryde; Elena A Turner; Olga R Ilkayeva; Dhaval P Bhatt; Matthew D Hirschey; Joel N Meyer
Journal:  Toxicology       Date:  2020-11-11       Impact factor: 4.221

Review 4.  The Base Excision Repair Pathway in the Nematode Caenorhabditis elegans.

Authors:  Noha Elsakrmy; Qiu-Mei Zhang-Akiyama; Dindial Ramotar
Journal:  Front Cell Dev Biol       Date:  2020-12-03

Review 5.  Xenobiotic metabolism and transport in Caenorhabditis elegans.

Authors:  Jessica H Hartman; Samuel J Widmayer; Christina M Bergemann; Dillon E King; Katherine S Morton; Riccardo F Romersi; Laura E Jameson; Maxwell C K Leung; Erik C Andersen; Stefan Taubert; Joel N Meyer
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2021-02-22       Impact factor: 8.071

6.  Enhanced Uptake of Arsenic Induces Increased Toxicity with Cadmium at Non-Toxic Concentrations on Caenorhabditis elegans.

Authors:  Chengcheng Pei; Lingyan Sun; Yanan Zhao; Shenyao Ni; Yaguang Nie; Lijun Wu; An Xu
Journal:  Toxics       Date:  2022-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.